Topography of alpha-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease.

Abnormal neuronal intermediate filament (IF) inclusions immunopositive for the type IV IF alpha-internexin have been identified as the pathological hallmark of neuronal intermediate filament inclusion disease (NIFID). We studied the topography of these inclusions in the frontal and temporal lobe in 68 areas from 10 cases of NIFID. In the cerebral cortex, CA sectors of the hippocampus, and dentate gyrus granule cell layer, the inclusions were distributed mainly in regularly distributed clusters, 50-800 microm in diameter. In seven cortical areas, there was a more complex pattern in which the clusters of inclusions were aggregated into larger super clusters. In 11 cortical areas, the size of the clusters approximated to those of the cells of origin of the cortico-cortical pathways but in the majority of the remaining areas, cluster size was smaller than 400 microm. The topography of the lesions suggests that there is degeneration of the cortico-cortical projections in NIFID with the formation of alpha-internexin-positive aggregates within vertical columns of cells. Initially, only a subset of cells within a vertical column develops inclusions but as the disease progresses, the whole of the column becomes affected. The corticostriate projection appears to have little effect on the cortical topography of the inclusions.
AuthorsR A Armstrong, N J Cairns
JournalEuropean journal of neurology (Eur J Neurol) Vol. 13 Issue 5 Pg. 528-32 (May 2006) ISSN: 1351-5101 [Print] England
PMID16722980 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Intermediate Filament Proteins
  • Nerve Tissue Proteins
  • alpha-internexin
  • Adult
  • Autopsy
  • Biomarkers
  • Brain (pathology)
  • Female
  • Humans
  • Inclusion Bodies (pathology)
  • Intermediate Filament Proteins (analysis)
  • Intermediate Filaments (pathology)
  • Male
  • Middle Aged
  • Nerve Tissue Proteins (analysis)
  • Neurodegenerative Diseases (mortality, pathology)
  • Neurons (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: